bisoprolol has been researched along with Addison Disease in 1 studies
Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.
Addison Disease: An adrenal disease characterized by the progressive destruction of the ADRENAL CORTEX, resulting in insufficient production of ALDOSTERONE and HYDROCORTISONE. Clinical symptoms include ANOREXIA; NAUSEA; WEIGHT LOSS; MUSCLE WEAKNESS; and HYPERPIGMENTATION of the SKIN due to increase in circulating levels of ACTH precursor hormone which stimulates MELANOCYTES.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campean, R | 1 |
| Hasun, M | 1 |
| Stöllberger, C | 1 |
| Bucher, J | 1 |
| Finsterer, J | 1 |
| Schnack, C | 1 |
| Weidinger, F | 1 |
1 other study available for bisoprolol and Addison Disease
| Article | Year |
|---|---|
Takotsubo-like syndrome triggered by fludrocortisone overdose for Addison's disease: a case report.
Topics: Addison Disease; Adult; Anti-Inflammatory Agents; Antihypertensive Agents; Biomarkers; Bisoprolol; D | 2016 |